Whilst PCR testing remains the gold standard for diagnosing SARS-CoV-2 infection, antigen testing provides an important alternative. This document explores the impact of antigen testing for various use cases and guides the implementation of these tests across different settings.

The document also incorporates guidance regarding eligibility criteria for testing and testing ports of entry. It is hoped that the guidelines will contribute to increased testing, which will assist us to identify and respond to outbreaks in a timely and effective manner.

*Please note*
The interim guidelines are based on what is currently known about the Coronavirus Disease 2019 (COVID-19). The National Institute for Communicable Diseases will update these interim guidelines as needed and as additional information becomes available.